Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
DNA Ginkgo Bioworks Holdings, Inc.
Square offers multiple tools to make life more simple for business owners. The company helps business owners send invoices, accept online payments and offer delivery, pickup and shipping options. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback